Kodiak Corp (KOD) - שווי שוק לרווח

Kodiak Pharma - לוגו גרפי של המנפיק KOD

The current P/E ratio on the GURU.Markets dynamic chart for Kodiak Sciences Inc. (KOD) demonstrates volatility, confirming the risks of trial failures and pressure from industry behemoths. The -25.80 metric indicates the status of an asset whose value is based on the ABC platform for rare injections. Meanwhile, Kodiak Sciences Inc. (KOD) relies on external contractors to optimize the security of delegating clinical processes.

KOD Kodiak Pharma: מכפיל P/E בטווח 04.07.2022 - 17.11.2026

פילוחים אנליטיים של חברת Kodiak Sciences Inc.

ניתוח מקיף של החברה:KOD (Kodiak Sciences)
מוצר המיוצר על ידי Kodiak Pharma

For Kodiak Sciences Inc. (KOD), which attracts leading ophthalmologists to combat retinal pathologies, the P/E ratio determines the investment payback period via net income. By analyzing the company's P/E fluctuations, an investor assesses the ratio of the asset's market value to its actual yield, making it possible to identify overvalued shares and confirm the financial stability of innovative developments amidst market volatility.